The role of dysfunctional HDL in atherosclerosis

The role of dysfunctional HDL in atherosclerosis

This review focuses on HDL function in modulating LDL oxidation and LDL-induced inflammation. Dysfunctional HDL has been identified in animal models and humans with chronic inflammatory diseases including atherosclerosis. The loss of antiinflammatory function correlated with a loss of function in re...

Full description

Bibliographic Details
Main Authors:	Mohamad Navab, Srinivasa T. Reddy, Brian J. Van Lenten, G.M. Anantharamaiah, Alan M. Fogelman
Format:	Article
Language:	English
Published:	Elsevier 2009-01-01
Series:	Journal of Lipid Research
Subjects:	inflammation high density lipoprotein LDL mimetic peptides L-4F D-4F
Online Access:	http://www.sciencedirect.com/science/article/pii/S0022227520306027

Similar Items

Lipoprotein inflammatory properties and serum amyloid A levels but not cholesterol levels predict lesion area in cholesterol-fed rabbits
by: Brian J. Van Lenten, et al.
Published: (2007-11-01)

Thematic review series: The Pathogenesis of Atherosclerosis The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL
by: Mohamad Navab, et al.
Published: (2004-06-01)

Enhancement by LDL of transfer of L-4F and oxidized lipids to HDL in C57BL/6J mice and human plasma
by: David Meriwether, et al.
Published: (2011-10-01)

Ambient ultrafine particles alter lipid metabolism and HDL anti-oxidant capacity in LDLR-null mice
by: Rongsong Li, et al.
Published: (2013-06-01)

A novel approach to oral apoA-I mimetic therapy[S]
by: Arnab Chattopadhyay, et al.
Published: (2013-04-01)

Source and role of intestinally derived lysophosphatidic acid in dyslipidemia and atherosclerosis
by: Mohamad Navab, et al.
Published: (2015-04-01)

Subcutaneous Administration of Apolipoprotein J-Derived Mimetic Peptide d-[113–122]apoJ Improves LDL and HDL Function and Prevents Atherosclerosis in LDLR-KO Mice
by: Andrea Rivas-Urbina, et al.
Published: (2020-05-01)

Intestine may be a major site of action for the apoA-I mimetic peptide 4F whether administered subcutaneously or orally[S]
by: Mohamad Navab, et al.
Published: (2011-06-01)

The Role of HDL and HDL Mimetic Peptides as Potential Therapeutics for Alzheimer’s Disease
by: Dustin Chernick, et al.
Published: (2020-09-01)

D-4F-mediated reduction in metabolites of arachidonic and linoleic acids in the small intestine is associated with decreased inflammation in low-density lipoprotein receptor-null mice
by: Mohamad Navab, et al.
Published: (2012-03-01)

Anti-inflammatory and cholesterol-reducing properties of apolipoprotein mimetics: a review
by: C. Roger White, et al.
Published: (2014-10-01)

D-4F reduces EO6 immunoreactivity, SREBP-1c mRNA levels, and renal inflammation in LDL receptor-null mice fed a Western diet
by: Georgette M. Buga, et al.
Published: (2008-01-01)

D-4F decreases brain arteriole inflammation and improves cognitive performance in LDL receptor-null mice on a Western diet
by: Georgette M. Buga, et al.
Published: (2006-10-01)

Cholesterol Binding Activity of ApoAI Mimetic Peptide L4F
by: Onkar, Sayali S.
Published: (2013)

Transgenic 6F tomatoes act on the small intestine to prevent systemic inflammation and dyslipidemia caused by Western diet and intestinally derived lysophosphatidic acid[S]
by: Mohamad Navab, et al.
Published: (2013-12-01)

A cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipids
by: Mohamad Navab, et al.
Published: (2001-08-01)

An apoA-I mimetic peptibody generates HDL-like particles and increases alpha-1 HDL subfraction in mice
by: Shu-Chen Lu, et al.
Published: (2012-04-01)

A novel method for oral delivery of apolipoprotein mimetic peptides synthesized from all L-amino acids
by: Mohamad Navab, et al.
Published: (2009-08-01)

Role of enterocyte stearoyl-Co-A desaturase-1 in LDLR-null mice
by: Pallavi Mukherjee, et al.
Published: (2018-10-01)

Tepung okra (Albelmoschus esculantus) menurunkan rasio kadar LDL terhadap HDL tikus hiperkolesterolemia
by: Ayu Febriyatna, et al.
Published: (2018-01-01)

PLTP deficiency improves the anti-inflammatory properties of HDL and reduces the ability of LDL to induce monocyte chemotactic activity
by: Daoguang Yan, et al.
Published: (2004-10-01)

The ApoA-I mimetic peptide 4F attenuates in vitro replication of SARS-CoV-2, associated apoptosis, oxidative stress and inflammation in epithelial cells
by: Theodoros Kelesidis, et al.
Published: (2021-01-01)

Selective modification of apoB-100 in the oxidation of low density lipoproteins by myeloperoxidase in vitro
by: Chao-yuh Yang, et al.
Published: (1999-04-01)

A biochemical fluorometric method for assessing the oxidative properties of HDL[S]
by: Theodoros Kelesidis, et al.
Published: (2011-12-01)

Development of synthetic high-density lipoprotein-based ApoA-I mimetic peptide-loaded docetaxel as a drug delivery nanocarrier for breast cancer chemotherapy
by: Miaomiao Gong, et al.
Published: (2019-01-01)

Non-high-density lipoprotein (non-HDL) cholesterol in adolescence as a predictor of atherosclerotic cardiovascular diseases in adulthood
by: Saeed Shoar, et al.
Published: (2021-06-01)

EVALUATION OF LDL-CHOLESTEROL & HDL-CHOLESTEROL, IN FEMALE HYPOTHYROID PATIENTS OF AGE 20-50 YEARS
by: Muhammad Shahzad Farooq, et al.
Published: (2015-03-01)

Structural requirements for antioxidative and anti-inflammatory properties of apolipoprotein A-I mimetic peptides
by: G.M. Anantharamaiah, et al.
Published: (2007-09-01)

Comparison of Mechanisms of Endothelial Cell Protections Between High-Density Lipoprotein and Apolipoprotein A-I Mimetic Peptide
by: Wenqi Xu, et al.
Published: (2019-07-01)

High-density Lipoproteins and Apolipoprotein A-I: Potential New Players in the Prevention and Treatment of Lung Disease
by: Elizabeth M. Gordon, et al.
Published: (2016-09-01)

Separation of the principal HDL subclasses by iodixanol ultracentrifugation
by: Nicola L. Harman, et al.
Published: (2013-08-01)

HDL efflux capacity, HDL particle size, and high-risk carotid atherosclerosis in a cohort of asymptomatic older adults: the Chicago Healthy Aging Study
by: R.Kannan Mutharasan, et al.
Published: (2017-03-01)

Association of lipoproteins and thyroid hormones with cognitive dysfunction in patients with systemic lupus erythematosus
by: Li Lu, et al.
Published: (2021-06-01)

Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3
by: Mohamad Navab, et al.
Published: (2000-09-01)

The Atherogenic Role of Circulating Modified Lipids in Atherosclerosis
by: Volha I. Summerhill, et al.
Published: (2019-07-01)

Beyond HDL-cholesterol increase: phospholipid enrichment and shift from HDL3 to HDL2 in alcohol consumers
by: Christian Schäfer, et al.
Published: (2007-07-01)

Association between Negatively Charged Low-Density Lipoprotein L5 and Subclinical Atherosclerosis in Rheumatoid Arthritis Patients
by: Chun-Yu Chang, et al.
Published: (2019-02-01)

Transintestinal transport of the anti-inflammatory drug 4F and the modulation of transintestinal cholesterol efflux[S]
by: David Meriwether, et al.
Published: (2016-07-01)

Overview of OxLDL and Its Impact on Cardiovascular Health: Focus on Atherosclerosis
by: Anastasia V. Poznyak, et al.
Published: (2021-01-01)

Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1
by: Mohamad Navab, et al.
Published: (2000-09-01)